Ellington Management Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-21,800
| Closed | -$121K | – | 531 |
|
|
2018
Q4 | $121K | Buy |
+21,800
| New | +$121K | 0.04% | 331 |
|
|
2018
Q2 | – | Sell |
-11,700
| Closed | -$112K | – | 479 |
|
|
2018
Q1 | $112K | Buy |
+11,700
| New | +$112K | 0.01% | 763 |
|
|
2017
Q4 | – | Sell |
-12,100
| Closed | -$238K | – | 566 |
|
|
2017
Q3 | $238K | Buy |
+12,100
| New | +$238K | 0.04% | 462 |
|
|
2017
Q1 | – | Sell |
-11,500
| Closed | -$120K | – | 658 |
|
|
2016
Q4 | $120K | Sell |
11,500
-5,700
| -33% | -$59.5K | 0.02% | 473 |
|
|
2016
Q3 | $156K | Buy |
+17,200
| New | +$156K | 0.04% | 576 |
|
|
2016
Q1 | – | Sell |
-44,906
| Closed | -$580K | – | 486 |
|
|
2015
Q4 | $580K | Buy |
44,906
+16,509
| +58% | +$213K | 0.2% | 83 |
|
|
2015
Q3 | $274K | Buy |
+28,397
| New | +$274K | 0.08% | 449 |
|